IL17A and dementia: Overall, the results reported by Chandra et al. (9) contribute to a growing rationale for targeting Th17 cells and IL-17 production in the periphery as part of therapeutic strategies for dementia and indicate that gut microbiota–based interventions should strive to modify this pathway.